About Milestone Pharmaceuticals
Headquartered in Montreal, with a growing subsidiary in Charlotte, NC
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Montreal, QC
- Founded
- 2007
- Company type
- Public Company
- Company profile name
- Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a patient-centric commercial-stage biopharmaceutical company dedicated to bringing innovative cardiology products to market. Our lead product, CARDAMYST™ (etripamil), is FDA approved for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. We are also dedicated to the continued clinical investigation of etripamil as a treatment for atrial fibrillation with rapid ventricular rate (AFib-RVR). At Milestone, everything we do is with the patient in mind. To learn more, visit www.milestonepharma.com.
Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/
Company locations
1111 Dr. Frederik-Philips, Montreal, QC H4M 2X6, CA
6210 Ardrey Kell Road, suite 650, Charlotte, NC 28277, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 13,309
- People linked to this company
- 129
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.